(Q36181251)

12 August 2017

Successful vaccination for Lyme disease: a novel mechanism (English)

1 reference

12 August 2017

0 references

Thanassi WT

1

1 reference

PubMed ID

15992056

12 August 2017

Schoen RT

series ordinal

2

1 reference

PubMed ID

15992056

12 August 2017

language of work or name

English

0 references

publication date

1 January 1999

1 reference

Expert Opinion on Investigational Drugs

12 August 2017

1 reference

12 August 2017

8

1 reference

12 August 2017

1

1 reference

12 August 2017

29-35

1 reference

Borrelia burgdorferi sp. nov.: Etiologic Agent of Lyme Disease

12 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Perspective on the development of vaccines against Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

The T helper cell response in Lyme arthritis: differential recognition of Borrelia burgdorferi outer surface protein A in patients with treatment-resistant or treatment-responsive Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Antigens of Borrelia burgdorferi recognized during Lyme disease. Appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Induction of an outer surface protein on Borrelia burgdorferi during tick feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Monoclonal antibodies specific for the outer surface protein A (OspA) of Borrelia burgdorferi prevent Lyme borreliosis in severe combined immunodeficiency (scid) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Antiborrelial activity of serum from rats injected with the Lyme disease spirochete

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Fc- and non-Fc-mediated phagocytosis of Borrelia burgdorferi by macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543784.8.1.29

21 January 2018

Identifiers

DOI

10.1517/13543784.8.1.29

1 reference

12 August 2017

1 reference

PubMed ID

15992056